Echo Testing Group

Echo Testing Group is a private Texas company focused on healthcare diagnostics and medical testing commercialization. Publicly available information indicates it was founded to bring the BT-MED diagnostic system to the United States and Canada, and it participated in Escher Biomedical Diagnostics, a joint venture formed with Biotrack BV. Through that relationship, the company was associated with commercialization of the BT-MED COV19 saliva-based molecular diagnostic test for SARS-CoV-2. The business appears to be more of a diagnostics commercialization and distribution vehicle than a traditional therapeutic biotech developer, with limited public disclosure on a broader independent pipeline.